ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.720,01
-1,47%
S&P 500
5.702,55
-0,19%
Dow Jones
42.063,36
0,09%
Euro vs US Dollar
1,11705
0,00%
Bitcoin
62.943,40
-0,68%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Edwards Lifesciences Corp (EW)

  7. Edwards Lifesciences Corp (EW) News

EW

Edwards Lifesciences (EW)

Edwards Lifesciences Corp
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:EW
DatumZeitQuelleÜberschriftSymbolFirma
17/09/202402h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
16/09/202423h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
12/09/202400h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
04/09/202401h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
03/09/202422h34Edgar (US Regulatory)Form 8-K - Current reportNYSE:EWEdwards Lifesciences Corp
03/09/202422h30Business WireEdwards Lifesciences Completes Sale of Critical CareNYSE:EWEdwards Lifesciences Corp
01/09/202400h58Business WireCORRECTING and REPLACING First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards ValvesNYSE:EWEdwards Lifesciences Corp
31/08/202418h35Business WireFirst All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards ValvesNYSE:EWEdwards Lifesciences Corp
21/08/202413h00Business WireEdwards Lifesciences to Present at the 2024 Wells Fargo Healthcare ConferenceNYSE:EWEdwards Lifesciences Corp
21/08/202401h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
20/08/202423h12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:EWEdwards Lifesciences Corp
19/08/202422h33Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
14/08/202423h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
14/08/202422h19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:EWEdwards Lifesciences Corp
31/07/202422h20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:EWEdwards Lifesciences Corp
31/07/202422h14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:EWEdwards Lifesciences Corp
25/07/202412h19IH Market NewsEarnings Updates: Ford Shares Fall 13% on EPS Miss, Stellantis Down 6%, Viking Therapeutics Up 20%, Unilever Up 5%NYSE:EWEdwards Lifesciences Corp
24/07/202422h26Edgar (US Regulatory)Form 8-K - Current reportNYSE:EWEdwards Lifesciences Corp
24/07/202422h15Business WireEdwards Lifesciences Reports Second Quarter ResultsNYSE:EWEdwards Lifesciences Corp
24/07/202422h15Business WireEdwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and EndotronixNYSE:EWEdwards Lifesciences Corp
17/07/202413h05Business WireEdwards Lifesciences to Host Earnings Conference Call on July 24, 2024NYSE:EWEdwards Lifesciences Corp
15/07/202415h04Edgar (US Regulatory)Form 8-K - Current reportNYSE:EWEdwards Lifesciences Corp
15/07/202415h00Business WireEdwards Lifesciences to Acquire InnovalveNYSE:EWEdwards Lifesciences Corp
11/07/202423h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
11/07/202422h17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:EWEdwards Lifesciences Corp
10/07/202423h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
10/07/202423h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
10/07/202422h41Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
10/07/202422h39Edgar (US Regulatory)Form 8-K - Current reportNYSE:EWEdwards Lifesciences Corp
09/07/202400h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
 Showing the most relevant articles for your search:NYSE:EW

Kürzlich von Ihnen besucht

FX
EURUSD
Euro vs US Dollar
NASDAQ
AMZN
Amazon.com
DBI
MDAX
MDAX
USOTC
BNPQY
BNP Paribas (QX)
COIN
XRPUSD
Ripple
TG
RHM
Rheinmetall
TG
BAS
BASF
CCOM
US100
US Tech 100
NYSE
DIS
Walt Disney
TG
432
Arbor Metals
TG
ALV
Allianz
COIN
DOGEUSD
Dogecoin
USOTC
DTEGY
Deutsche Telekom (QX)
TG
LHA
Deutsche Lufthansa
DBI
SDXP
SDAX
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten